These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 20044599
1. Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7. Cludts S, Decaestecker C, Mahillon V, Chevalier D, Kaltner H, André S, Remmelink M, Leroy X, Gabius HJ, Saussez S. Anticancer Res; 2009 Dec; 29(12):4933-40. PubMed ID: 20044599 [Abstract] [Full Text] [Related]
2. Galectin-3 upregulation during tumor progression in head and neck cancer. Saussez S, Decaestecker C, Mahillon V, Cludts S, Capouillez A, Chevalier D, Vet HK, André S, Toubeau G, Leroy X, Gabius HJ. Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282 [Abstract] [Full Text] [Related]
3. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ, Leroy X. Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601 [Abstract] [Full Text] [Related]
4. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7. Saussez S, Cludts S, Capouillez A, Mortuaire G, Smetana K, Kaltner H, André S, Leroy X, Gabius HJ, Decaestecker C. Int J Oncol; 2009 Feb; 34(2):433-9. PubMed ID: 19148478 [Abstract] [Full Text] [Related]
5. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I, Gabius HJ, Kiss R. Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763 [Abstract] [Full Text] [Related]
6. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Saussez S, Decaestecker C, Lorfevre F, Cucu DR, Mortuaire G, Chevalier D, Wacreniez A, Kaltner H, André S, Toubeau G, Camby I, Gabius HJ, Kiss R. Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012 [Abstract] [Full Text] [Related]
7. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue. Alves PM, Godoy GP, Gomes DQ, Medeiros AM, de Souza LB, da Silveira EJ, Vasconcelos MG, Queiroz LM. Pathol Res Pract; 2011 Apr 15; 207(4):236-40. PubMed ID: 21397408 [Abstract] [Full Text] [Related]
8. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA. Laryngoscope; 2001 Jun 15; 111(6):1079-87. PubMed ID: 11404625 [Abstract] [Full Text] [Related]
9. Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers. Juhász A, Bárdos H, Répássy G, Adány R. Laryngoscope; 2000 Jan 15; 110(1):84-92. PubMed ID: 10646721 [Abstract] [Full Text] [Related]
10. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J. Magy Onkol; 2009 Mar 15; 53(1):51-9. PubMed ID: 19318327 [Abstract] [Full Text] [Related]
11. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Capouillez A, Debauve G, Decaestecker C, Filleul O, Chevalier D, Mortuaire G, Coppée F, Leroy X, Belayew A, Saussez S. Histopathology; 2009 Jul 15; 55(1):77-90. PubMed ID: 19614770 [Abstract] [Full Text] [Related]
12. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Kim CH, Kim J, Kahng H, Choi EC. Ann Surg Oncol; 2007 May 15; 14(5):1565-74. PubMed ID: 17294073 [Abstract] [Full Text] [Related]
13. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC, Chen YL, Jin YT. Oral Oncol; 2008 Apr 15; 44(4):325-34. PubMed ID: 17588803 [Abstract] [Full Text] [Related]
14. Galectin-1: a link between tumor hypoxia and tumor immune privilege. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, Koong AC. J Clin Oncol; 2005 Dec 10; 23(35):8932-41. PubMed ID: 16219933 [Abstract] [Full Text] [Related]
15. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ. J Exp Clin Cancer Res; 2004 Jun 10; 23(2):277-83. PubMed ID: 15354413 [Abstract] [Full Text] [Related]
17. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer. Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM. Oncol Rep; 2007 Jul 10; 18(1):121-6. PubMed ID: 17549356 [Abstract] [Full Text] [Related]
18. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, Wolden SL, Narayana A, Kraus D, Shah JP, Pfister DG. Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):459-68. PubMed ID: 17493769 [Abstract] [Full Text] [Related]
20. [Expression of alpha-v integrin subunit in the laryngeal and hypopharyngeal squamous cell carcinomas and its relationship with tumor angiogenesis]. Lu JG, Xiao YL, Kan X, Jin DJ. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan 01; 43(1):46-50. PubMed ID: 18357713 [Abstract] [Full Text] [Related] Page: [Next] [New Search]